Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: A multicenter study

被引：0

作者：

Nigro, O. ^{[1
]}

Cortellini, A. ^{[2
]}

Giusti, R. ^{[3
]}

Marchetti, P. ^{[3
]}

De Galitiis, F. ^{[4
]}

Di Pietro, F. R. ^{[4
]}

Bersanelli, M. ^{[5
]}

Lazzarin, A. ^{[5
]}

Galetta, D. ^{[6
]}

Pizzutillo, P. ^{[6
]}

Santini, D. ^{[7
]}

Torniai, M. ^{[8
]}

De Giglio, A. ^{[9
]}

Russo, A. ^{[10
,11
]}

Silva, R. R. ^{[12
]}

Bolzacchini, E. ^{[13
]}

Natoli, C. ^{[14
]}

Rijavec, E. ^{[15
]}

Vallini, I. ^{[1
]}

Pinotti, G. ^{[1
]}

机构：

[1] Osped Circolo Varese, ASST Sette Laghi, Med Oncol, Varese, Italy

[2] St Salvatore Hosp, Med Oncol, Laquila, Italy

[3] Azienda Osped Univ St Andrea, Med Oncol, Rome, Italy

[4] IRCCS, IDI, Oncol & Oncol Dermatol, Rome, Italy

[5] Azienda Osped Univ Parma, Med Oncol, Parma, Italy

[6] Clin Canc Ctr Giovanni Paolo II, Thorac Oncol Unit, Bari, Italy

[7] Campus Biomed, Med Oncol, Rome, Italy

[8] Univ Politecn Marche, Azienda Osped Univ Ospedali Riuniti Umberto I, Med Oncol, Ancona, Italy

[9] Osped S Maria Misericordia, Oncol Med, Perugia, Italy

[10] AO Papardo, Med Oncol, Messina, Italy

[11] Dept Human Pathol, Messina, Italy

[12] Area Vasta 2, ASUR Marche, Med Oncol, Fabriano, Italy

[13] Osped St Anna, ASST Lariana, Med Oncol, Como, Italy

[14] SS Annunziata Hosp, Med Oncol, Chieti, Italy

[15] Policlin Milano, Med Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

55P

引用

页数：1

共 50 条

[31] Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE).
Nardin, Charlee
Dalle, Stephane
Leccia, Marie Therese
Mortier, Laurent
Dalac-Rat, Sophie
Dutriaux, Caroline
Legoupil, Delphine
Montaudie, Henri
Dereure, Olivier
De Quatrebarbes, Julie
Granel-Brocard, Florence
Le-Bouar, Myrtille
Charles, Julie
Brunet-Possenti, Florence
Dreno, Brigitte
Lefevre, Wendy
Allayous, Clara
Lebbe, Celeste
Aubin, Francois
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[32] New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer
Hall, Kevin H.
Liu, Yuan
Jiang, Chen
Harvey, R. Donald
PHARMACOTHERAPY, 2020, 40 (02): : 133 - 141
[33] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
Duruisseaux, Michael
Rouquette, Isabelle
Adam, Julien
Cortot, Alexis
Cazes, Aurelie
Gibault, Laure
Damotte, Diane
Lantuejoul, Sylvie
ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
[34] Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
Bhardwaj, Maitry
Chiu, Mei Nee
Sah, Sangeeta Pilkhwal
CUTANEOUS AND OCULAR TOXICOLOGY, 2022, 41 (01) : 73 - 90
[35] PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
Yang, Tianrui
Kong, Ziren
Ma, Wenbin
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) : 546 - 553
[36] Neoadjuvant PD-1/PD-L1 Immune Checkpoint Inhibitors in Solid Tumors
Zhao, S.
Li, X.
Wang, S.
Wang, Y.
Huang, D.
Da, Y.
Song, Z.
Chen, J.
Manegold, C.
Peng, L.
Xu, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S651
[37] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Iosune Baraibar
Ignacio Melero
Mariano Ponz-Sarvise
Eduardo Castanon
Drug Safety, 2019, 42 : 281 - 294
[38] Immune-related adverse events (IRAEs) in metastatic lung cancer patients receiving PD-1/PD-L1 inhibitors and thoracic radiotherapy.
Hwang, William L.
Niemierko, Andrzej
Willers, Henning
Keane, Florence K.
Gainor, Justin F.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[39] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Baraibar, Iosune
Melero, Ignacio
Ponz-Sarvise, Mariano
Castanon, Eduardo
DRUG SAFETY, 2019, 42 (02) : 281 - 294
[40] Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
Le Biannic, Raphael
Magnez, Romain
Klupsch, Frederique
Leleu-Chavain, Natascha
Thiroux, Bryan
Tardy, Morgane
El Bouazzati, Hassiba
Dezitter, Xavier
Renault, Nicolas
Vergoten, Gerard
Bailly, Christian
Quesnel, Bruno
Thuru, Xavier
Millet, Regis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236

← 1 2 3 4 5 →